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A B S T R A C T
Background: The quadrivalent human papillomavirus vaccine was licensed in Denmark in 2006. Unlike
women, men are not oﬀered human papillomavirus vaccination free of charge but can have it at their own
expense. We investigated human papillomavirus vaccine uptake by men in Denmark and the socioeconomic
factors that may predict human papillomavirus vaccination.
Methods: Using the Civil Registration System, we identiﬁed all boys and men aged 9–26 years in 2006–2013
and their mothers. By linkage to Statistics Denmark and the National Prescription Registry, we obtained
information on socioeconomic variables and human papillomavirus vaccination during the study period. Using
Cox regression, we examined the associations between socioeconomic variables and human papillomavirus
vaccination.
Results: Between 2006 and 2013, 6253 (0.8%) males aged 9–26 years were vaccinated against human
papillomavirus. The strongest predictor identiﬁed was ethnicity. Males who were immigrants (hazard ratio,
0.12; 95% conﬁdence interval, 0.08–0.180) or sons of immigrant parents (hazard ratio, 0.13; 95% conﬁdence
interval, 0.10–0.17) were less likely to be vaccinated than Danish males. Additionally, sons of mothers who were
unemployed, unmarried, had a low income, and basic education initiated human papillomavirus vaccination
less frequently. Finally, sons of mothers who were physicians or nurses were more likely to be vaccinated than
sons of other highly educated mothers.
Conclusion: We found low uptake, with social disparities in human papillomavirus vaccination of boys and
young men in Denmark.
1. Introduction
Human papillomavirus (HPV) is one of the most common sexually
transmitted infections. Persistent infection with high-risk HPV types is
associated with cervical cancer, which is the fourth most common
cancer in women worldwide [1]. HPV is also associated with a number
of other anogenital and oropharyngeal cancers, many of which also
aﬀect men [2]. Additionally, low-risk HPV types are associated with
genital warts, which are common in both women and men [3].
Currently, three vaccines against HPV are available, and more than
57 countries have started national HPV immunization programmes
since 2007. Most of these programmes are directed to women, as
cervical cancer is the most common HPV-related cancer [3]; however,
there is an ongoing discussion about whether boys and men should also
be included in HPV immunization programmes, which would not only
protect men but would probably increase the protection of women
through a herd eﬀect.
The quadrivalent HPV vaccine has been found to be eﬀective and
generally well tolerated in both women and men [3–5]. For boys, the
vaccine has been approved by the European Medicines Agency and the
United States Food and Drug Administration for the prevention of anal
cancers, anal precancerous lesions, and genital warts [4,5]. Since 2013,
Australia has vaccinated 12–13-year-old boys free of charge [6].
Likewise, both Canada and the USA recommend routine HPV vaccina-
tion of adolescent boys [7,8]. In Europe, Austria is the only country that
includes males in the national HPV immunization programme [9].
In Denmark, HPV vaccine was included for girls in the childhood
vaccination programme in January 2009, and the ﬁrst catch-up
programme for girls up to 15 years of age started in October 2008;
the second free catch-up vaccination programme, starting in August
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2012, covers women up to 27 years of age. The programme has reached
high coverage: 75–91% of eligible girls receive at least one dose, and
the majority of those who initiate vaccination complete the programme
[6,7]. Boys and men are not included in the vaccination programme,
but, since licensure of the quadrivalent HPV vaccine in 2006, they have
been able to purchase the vaccine at their own expense.
To our knowledge, there are no studies on HPV vaccine uptake
among boys in Europe. Several studies on the acceptability of HPV
vaccination by young men and parents of boys show good acceptability
and identify knowledge about HPV and the HPV vaccine as the most
inﬂuential factor in the decision to be vaccinated [8–12]. A Danish
study also showed a high level of acceptability of HPV vaccination
among parents of 12–15-year-old boys. Although 45% were willing to
cover the cost of vaccination, this does not necessarily predict high
uptake [13,14]. HPV vaccination uptake among adolescent boys has
been studied in the USA, where several studies showed that racial and
socioeconomic factors are associated with uptake [15–20]. Most of the
studies were based on surveys and were conducted after routine HPV
vaccination of boys and men was recommended in the USA.
The aim of this population-based register study was to determine
nationwide HPV vaccine uptake among boys and men in Denmark and
the socioeconomic and demographic factors that might predict initia-
tion of vaccination. As knowledge about HPV has been shown to be an
important predictor of acceptability [13] of vaccination, we also studied
whether sons of health care professionals are more likely to receive
HPV vaccination.
2. Methods
In Denmark, each citizen is assigned a 10-digit personal identiﬁca-
tion number, which can be used as key identiﬁer when linking
individual information between national registers. From the Civil
Registration System, we identiﬁed all boys and men aged 9–26 years
living in Denmark in 2006–2014 and included them in an open cohort.
The participants entered the cohort on 1 October 2006, or at the time
of their 9th birthday, whichever came last. We continued follow-up
until 30 June 2014, their 26th birthday, or date of emigration or death,
whichever occurred ﬁrst. We also identiﬁed the parents of the study
population and obtained data on their socioeconomic variables from
population-based registers at Statistics Denmark. The study protocol
was approved by the Danish Data Protection Agency.
To identify vaccinated boys and men, we linked the cohort to the
Danish National Prescription Register, which contains data on all
prescriptions redeemed in Danish community pharmacies. HPV vac-
cines are identiﬁed by anatomical therapeutic chemical (ATC) codes.
We obtained information on all males in the cohort who redeemed at
least one prescription for either the bivalent (ATC-code J07BM02) or
the quadrivalent HPV vaccine (ATC-code J07B01).
We used ethnicity, income, education, employment status, and
marital status as indicators of socioeconomic status of the mothers. We
also identiﬁed mothers who were physicians or nurses. All measures
were of the mothers of the boys and men in the study population,
except for ethnicity, which was determined for the males themselves. If
data were not available on the mother, information on the father was
used instead.
Ethnicity was divided into three categories: Danish (both mother
and son born in Denmark), descendant (mother born outside
Denmark, son born in Denmark), and immigrant (son born outside
Denmark). Education was divided into basic (primary school), voca-
tional (high school, secondary school or vocational education), and
higher (bachelor or higher university degree). In an additional analysis
of education, we categorized nurses and physicians in separate groups.
Disposable income was calculated as income after deduction of taxes,
divided into tertiles, and categorized as low, middle, or upper.
Employment status was categorized as employed, unemployed, and
uncategorized, which included housewives and students. Marital status
was categorized as married, widowed, divorced, or unmarried.
2.1. Statistical analysis
We used Kaplan-Meier plots to illustrate the cumulative probability
of vaccination according to attained age. We constructed plots for
ethnicity, mother's education, income, employment status, and marital
status. We additionally plotted education to include the sons of
physicians and nurses as separate categories. We used a Cox propor-
tional hazards model to compare vaccination initiation stratiﬁed by
birth cohort, using attained age as the underlying time scale. We
calculated both crude hazard ratios (HRs) and mutually adjusted HRs
for participants for whom complete information on all the variables
was available and mutually adjusted HRs with all those for whom data
were missing, included as a separate category “unknown”. We made the
same calculations for boys who received three vaccine doses. As almost
all who initiated vaccination also completed the regime, and as we
found the same socio-economic pattern in initiation and completion of
vaccination, we only show data for initiation of HPV vaccination.
The proportional hazards assumption was tested with scaled
Schoenfeld residuals, which showed a signiﬁcant trend after the age
of 18 years for ethnicity and education of the mother. Thus, we ﬁtted
separate models for 9–18-year-olds and 19–26-year-olds for those
variables. The statistical analyses were performed with the statistical
software R, version 3.1.2. [21] The level of signiﬁcance was set to 5%,
and two-sided tests were used in all analyses.
3. Results
A total of 809,656 boys and men were included in the study, of
whom 6253 (0.8%) initiated HPV vaccination and 4283 completed the
regime with three doses during 2006–2014. Most were vaccinated
towards the end of the period, so the diﬀerence between the number
who initiated and completed vaccination reﬂects that many did not
have time to complete vaccination before 2014. Almost half of those
who were vaccinated (49%) were 12–15 years old, while 24% were 16–
18 years, 3% were younger than 12 years, 14% were 19–22 years and
10% were 23–26 years old at initiation of HPV vaccination. Table 1
shows the characteristics of the vaccinees and socioeconomic char-
acterization of the mothers. The percentage of vaccinated boys and men
was low in all birth cohorts, ranging from 0.03% in the 1979–1984
birth cohort to 1.9% in the 1994–1999 birth cohort.
Fig. 1 shows the probability of initiation of vaccination with age as
the underlying timescale stratiﬁed by ethnicity and indicators of the
mother's socioeconomic status (education, disposable income, employ-
ment status, and marital status). The ﬁgure shows a low probability for
initiation of vaccination among all boys and men, regardless of socio-
economic position. There were, however, diﬀerences in the levels of
socioeconomic predictors. For instance, vaccination was more likely
among ethnic Danes than immigrants or descendants and among sons
of mothers with a high income, mothers who were employed, and
mothers who were married. In relation to the mother's education, we
found that sons of women with a high level of education were more
likely to be vaccinated than those of women with vocational training or
basic education. When nurses and physicians were analysed as separate
categories (Fig. 2), the sons of mothers who were nurses or (especially)
physicians had a higher probability of being vaccinated than the sons of
other women with higher education.
We analysed the importance of the socio-economic indicators after
adjustment for age and after mutual adjustment. Table 2 shows the
relative probability of being vaccinated in relation to socioeconomic
status, expressed as unadjusted and mutually adjusted hazard ratios.
We found a strong correlation between vaccine initiation and ethnicity.
Immigrants (HR: 0.12 95% CI: 0.08–0.18) and descendants of
immigrants (HR: 0.13 95% CI: 0.10–0.17) were less likely to initiate
vaccination than ethnic Danes. Moreover, we found signiﬁcantly less
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initiation among sons of mothers with vocational (HR: 0.43 95% CI:
0.40–0.45) or basic (HR: 0.17 95% CI: 0.16–0.19) education than
among those of mothers with higher education. Likewise, we found a
signiﬁcant diﬀerence in vaccine initiation by the income and employ-
ment status of the mother. High income was associated with a greater
likelihood of initiation than middle income (HR: 0.43 95% CI: 0.41–
0.46) or low (HR: 0.30 95% CI: 0.28–0.32), and sons of unemployed
mothers (HR: 0.31 95% CI: 0.28–0.35) were less likely to be vaccinated
than sons of employed mothers. Finally, the sons of married mothers
were more likely to be vaccinated than those of unmarried mothers
(HR: 0.58 95% CI: 0.53–0.63), widowed mothers (HR: 0.68 95% CI:
0.48–0.95), or divorced mothers (HR: 0.61 95% CI: 0.56–0.67).
In the mutually adjusted model, we found similar results for most of
the variables. The only substantial diﬀerence was that uncategorized
employment of the mother appeared to signiﬁcantly increase the
likelihood of vaccination of a son as compared with the sons of
employed mothers (HR: 1.83 95% CI: 1.53–2.18). In a sensitivity
analysis, we included participants for whom information was missing
information ("unknown" in the mutually adjusted model); this did not
signiﬁcantly alter any of the calculated HRs (data not shown).
When we tested the assumption of proportionality, we found a
change in the relative hazard of some variables around the age of 19
years. We therefore calculated separate HRs for 9–18-year-olds and
19–26-year-olds for all variables and tested whether there was a
signiﬁcant diﬀerence between the HRs by age group (data not shown).
The eﬀects of both ethnicity and mother's education were signiﬁcantly
smaller in 19–26-year-olds than in younger boys, although the general
pattern was the same. The HR for being vaccinated was 0.06 (95% CI:
0.03–0.13) for immigrants aged 9–18 years when compared with
ethnic Danes, while that of 19–26-year-old immigrants was 0.20 (95%
CI: 0.13–0.33). A similar result was found for sons of immigrants
(HR9–18: 0.11; 95% CI: 0.08–0.15; HR19–26: 0.25; 95% CI: 0.16–0.41).
Likewise, sons of mothers with basic education had an HR of being
vaccinated of 0.15 (95% CI: 0.13–0.17) in the younger age group and
0.27 (95% CI: 0.22–0.32) in the older age group when compared with
sons of mothers with high education. Sons of mothers with vocational
training were also less likely to be vaccinated than sons of mothers with
high education (HR9–18: 0.41; 95% CI: 0.39–0.44; HR19–26: 0.47; 95%
CI: 0.42–0.53).
4. Discussion
In this nationwide register-based cohort study, we found a low
uptake of the HPV vaccine (0.8%) among Danish boys and men aged
9–26 years in 2006–2014. Moreover, we found substantial social
inequality in vaccination, with less uptake and completion of a three
dose vaccination regime among more socioeconomically disadvantaged
boys (measured by employment status, income, education, and marital
status of the mother). Likewise, less uptake and completion were found
among immigrants and descendants of immigrants, even after adjust-
ment for the other indicators of socioeconomic status. Sons of mothers
who were physicians or nurses were more likely to be vaccinated than
sons of mothers with other higher education.
In line with our results, a study in the USA showed low male uptake
of HPV vaccination before routine vaccination of men was recom-
mended [19]. In 2010, only 2% of 11–17-year-old boys had received at
least one dose of the quadrivalent HPV vaccine [19].
In the present study, one of the most inﬂuential predictors of HPV
vaccination was ethnicity, ethnic Danes being signiﬁcantly more likely
to be vaccinated than either immigrants or descendants. This ﬁnding is
in line with previous studies on parents’ acceptance of HPV vaccination
for their sons [9,12]. Most studies on uptake in the USA, however,
indicated that white citizens had a lower uptake than Hispanic and
black citizens and immigrants [16–18,20]. In our study, the lower
uptake by immigrants and descendants might be due to cultural or
language barriers. Another contributing factor might be that immi-
grants in Denmark aged < 18 years have less contact with their general
practitioner than non-immigrants [22]. They thus have less opportu-
nity to receive information or a recommendation from their primary
health care provider, which is an important predictor of HPV vaccina-
tion [23].
We found social disparities in respect of the mother's marital status,
education, income, and employment, with a greater likelihood of
vaccination if the mother was married, employed, had a high income,
and had higher education. This ﬁnding is in line with that of a Danish
study on HPV vaccine uptake by girls, which showed social disparities
in uptake even when vaccination was free of charge in the HPV
vaccination programme [24]. The 10–15% of girls in Denmark who
are eligible for free HPV vaccination but are not vaccinated generally
have lower socioeconomic status. In contrast, in the USA, studies on
uptake by boys have found that higher education and income of the
mother was either insigniﬁcant or associated with lower uptake
[17,18,25]. The diﬀerence from our results may be due to the fact that
US programs provide free vaccination for boys of lower socioeconomic
status, while parents in Denmark have to cover the cost of vaccination
for their sons. Moreover, our study was register-based, while the US
Table 1
Characteristics of human papillomavirus-vaccinated boys and men aged 9–26 years in
Denmark, 2006–2013.
Variable Human Papillomavirus vaccination
n Vaccinated %
Birth cohort
1979–1984 147,252 44 (0.03)
1984–1989 152,819 668 (0.4)
1989–1994 173,592 1427 (0.8)
1994–1999 172,793 3263 (1.9)
1999–2001 66,362 727 (1.1)
2001–2004 96,838 124 (0.1)
Age at vaccination (years)
< 12 179
12–15 3073
16–18 1510
19–22 877
23–26 614
Boy’s or man’s ethnicity
Danish 714,133 6161 (0.9)
Descendant 43,539 57 (0.1)
Immigrant 34,683 24 (0.8)
Unknown 11,048 11 (0.1)
Mother’s education
Higher 253,979 3601 (1.4)
Vocational 375,028 2216 (0.6)
Basic 142,495 378 (0.3)
Unknown 38,154 58 (0.2)
Mother’s income
High 272,582 3794 (1.4)
Middle 276,808 1601 (0.6)
Low 239,519 829 (0.4)
Unknown 20,747 29 (0.1)
Mother’s employment status
Employed 627,302 5700 (0.9)
Unemployed 139,215 372 (0.3)
Uncategorized 22,392 152 (0.7)
Unknown 20,747 29 (0.1)
Mother’s marital status
Married 551,267 4973 (0.9)
Widow 9061 34 (0.4)
Divorced 96,241 511 (0.5)
Unmarried 118,492 651 (0.6)
Unknown 34,595 84 (0.2)
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studies were based on surveys, which are more vulnerable to selection
bias; i.e. people of high socioeconomic status respond more frequently.
The probability of vaccination was much higher for sons of nurses
or physicians than for sons of other highly educated mothers. This is
not surprising, as knowledge about HPV and HPV vaccination and a
recommendation from a health care provider have been found to be the
Fig. 1. Cumulative probability of boys and men receiving at least one dose of human papillomavirus vaccine by age 9–26 years, stratiﬁed by male ethnicity and the income, employment
status, marital status, and education of the mother.
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most important predictors of vaccine uptake or acceptability
[11,13,17,18,25,26]. Physicians and nurses are expected to be more
knowledgeable about the beneﬁts and drawbacks of vaccination than
the general population. In Denmark, the HPV vaccine has been
promoted mainly as a vaccine against cervical cancer, and some people
may therefore not know that HPV-related diseases also aﬀect men.
Furthermore, as routine HPV vaccination of boys is not recommended
in Denmark, parents may consider that the risk of boys for HPV-related
disease is not high. The social gradient in HPV vaccination frequency
among boys and men found in our study may be due to the cost of the
vaccine, so that it is aﬀordable only for high-income families. It is also
possible that parents with higher socioeconomic status are simply
better informed about HPV and the HPV vaccine.
We chose to use predictors of the socioeconomic status only of the
mother and not the father or the boy or man himself. In a similar study
in Norway on predictors of HPV vaccination in girls and women,
information on both the father and the mother was used; the socio-
economic status of the mother was found to be the stronger predictor
[27]. In our study, the eﬀects of ethnicity and the mother's education
were signiﬁcantly smaller after the age of 18 years, although still
present. A likely explanation is that predictors of the socioeconomic
status of boys become more important as they grow up.
An important strength of the study was the use of information from
nationwide population-based registers and accurate linkage between
them with the unique personal identiﬁcation number, which limits the
risk for recall bias, increases generalizability, and virtually eliminates
loss to follow up. The potential limitations of the study include missing
information on some socioeconomic determinants; however, this was
minimal. If some boys were vaccinated without a prescription, perhaps
because they were the sons of health care workers, this would have led
to underestimation of the eﬀect of socioeconomic factors on vaccine
initiation, as the sons of health care workers generally have higher
socioeconomic status. The determinants are highly correlated, and
unadjusted estimates may be confounded by the other factors; how-
ever, even after mutual adjustment, the overall pattern did not change.
4.1. Conclusion
This study on HPV vaccine uptake among boys and men in
Denmark, who are not covered by the national HPV immunization
program, shows low uptake and signiﬁcant social disparity.
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Fig. 2. Cumulative probability of boys and men receiving at least one dose of human
papillomavirus vaccine by age 9–26 years, stratiﬁed by education of the mother.
Table 2
Hazard ratios (HRs) and 95% confidence intervals (CIs) for initiation of human
papillomavirus vaccination based on indicators of socioeconomic status of Danish boys
and men aged 9–26 years.
Variable Unadjusted Adjusted*
HR 95% CI HR 95% CI
Boy’s or man’s ethnicity
Danish 1 Reference 1 Reference
Descendant 0.13 0.10–1.17 0.22 0.17–0.29
Immigrant 0.12 0.08–0.18 0.20 0.13–0.30
Mother’s education
Higher 1 Reference 1 Reference
Vocational 0.43 0.40–0.45 0.52 0.50–0.55
Basic 0.17 0.16–0.19 0.28 0.25–0.31
Mother’s income
High 1 Reference 1 Reference
Middle 0.43 0.41–0.46 0.58 0.55–0.62
Low 0.29 0.28–0.32 0.53 0.48–0.58
Mother’s employment status
Employed 1 Reference 1 Reference
Unemployed 0.31 0.28–0.35 0.83 0.74–0.93
Uncategorized 0.81 0.69–0.95 1.83 1.53–2.18
Mother’s marital status
Married 1 Reference 1 Reference
Widow 0.68 0.48–0.95 0.72 0.51–1.01
Divorced 0.61 0.56–0.67 0.71 0.65–0.78
Unmarried 0.59 0.53–0.63 0.69 0.64–0.75
* Mutually adjusted.
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